Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark Finland France +10
  • Long-term safety study of oral etavopivat tablets in children, adolescents and adults with sickle cell disease or thalassaemia who completed previous etavopivat treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Italy Spain
  • Study on Treating Acute Osteomyelitis in Children with Amoxicillin and Cloxacillin Compared to Standard Hospital Care

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma

    Recruiting

    4 1 1
    Austria Belgium Bulgaria Czechia Denmark Finland +9
  • Study of Ruxolitinib and Chemotherapy Drug Combination for Children with Acute Lymphoblastic Leukemia and JAK/STAT Pathway Activation

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Poland
  • Study on the Effectiveness of Dexamethasone in Preventing Prenatal Virilization in Female Patients with Congenital Adrenal Hyperplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Title: Study of ultrasound-assisted carboplatin therapy with SonoVue for children with recurrent malignant brain tumors using blood-brain barrier disruption

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • A study of tranexamic acid to reduce blood loss during hip surgery in children with hip dysplasia and other hip conditions

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

    Recruiting

    3 1 1 1
    Austria Belgium Czechia Denmark Finland France +13
  • Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Belgium France Italy The Netherlands Spain Sweden